Literature DB >> 15280081

Myocardial contrast echocardiography in assessing microcirculation in baboons with chagas disease.

Miguel Zabalgoitia1, Jaime Ventura, Jose L Lozano, Lori Anderson, K D Carey, G B Hubbard, Jeff T Williams, John L Vandeberg.   

Abstract

OBJECTIVE: Microvascular abnormalities have been postulated in the pathogenesis of chagasic cardiomyopathy. The objective of this study was to evaluate the relationship between coronary microcirculation and systolic function impairment in baboons with Chagas disease using myocardial contrast echocardiography (MCE).
METHODS: Seventeen seropositive (5 males, 12 females; mean age 20 years) and 13 age- and gender-matched seronegative baboons underwent MCE using intravenous octafluoropropane human albumin microspheres. Color-coding was used to enhance tissue contrast in assessing regional myocardium uniformity and texture. Dipyridamole (0.54 mg/kg) was given to a subset of 4 animals to challenge coronary flow reserve. Systolic indices included left ventricular fractional shortening, velocity of circumferential fiber shortening, and left and right ventricular ejection fractions.
RESULTS: Four of the 17 (24%) seropositive primates had decreased fractional shortening (25 +/- 8% vs. 40 +/-5%, p <.005), velocity of circumferential fiber shortening (1.05 +/- 0.36 circ/s vs. 1.84 +/- 0.23 circ/s, p <.0001), and reduced right ventricular ejection fraction (44 +/- 9% vs. 54 +/- 4%, p <.05) compared to other seropositive animals. Seropositive and seronegative groups showed no significant differences on the coronary microcirculation pattern as evaluated by MCE, including the 4 baboons with systolic function impairment. Moreover, coronary flow vasoreactivity resulted in a significant increase in myocardial flow as detected by color-coding masking.
CONCLUSIONS: Chagasic heart disease is present in 24% of seropositive baboons spontaneously infected with Trypanosoma cruzi. MCE reveals a discrepancy between coronary microcirculation at rest and alterations in myocardial contractility, suggesting preservation of the microvascular integrity in this unique animal model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280081     DOI: 10.1080/10739680490425976

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  9 in total

1.  Trypanosoma cruzi in non-human primates with a history of stillbirths: a retrospective study (Papio hamadryas spp.) and case report (Macaca fascicularis).

Authors:  Jessica L Grieves; Gene B Hubbard; Jeff T Williams; John L Vandeberg; Edward J Dick; Juan C López-Alvarenga; Natalia E Schlabritz-Loutsevitch
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

2.  Natural Chagas disease in four baboons.

Authors:  Jeff T Williams; Edward J Dick; John L VandeBerg; Gene B Hubbard
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

3.  Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells.

Authors:  Ghada S Hassan; Shankar Mukherjee; Fnu Nagajyothi; Louis M Weiss; Stefka B Petkova; Cecilia J de Almeida; Huan Huang; Mahalia S Desruisseaux; Boumediene Bouzahzah; Richard G Pestell; Chris Albanese; George J Christ; Michael P Lisanti; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Advances in imaging of animal models of Chagas disease.

Authors:  Linda A Jelicks; Herbert B Tanowitz
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

5.  Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats.

Authors:  Jian-Jun Wen; Shivali Gupta; Zhangjun Guan; Monisha Dhiman; David Condon; Charles Lui; Nisha Jain Garg
Journal:  J Am Coll Cardiol       Date:  2010-06-01       Impact factor: 24.094

6.  Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.

Authors:  Denise Mayumi Tanaka; Luciano Fonseca Lemos de Oliveira; José Antônio Marin-Neto; Minna Moreira Dias Romano; Eduardo Elias Vieira de Carvalho; Antonio Carlos Leite de Barros Filho; Fernando Fonseca França Ribeiro; Jorge Mejia Cabeza; Carla Duque Lopes; Camila Godoy Fabricio; Norival Kesper; Henrique Turin Moreira; Lauro Wichert-Ana; André Schmidt; Maria de Lourdes Higuchi; Edécio Cunha-Neto; Marcus Vinícius Simões
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

7.  Transmission of Chagas disease via blood transfusions in 2 immunosuppressed pigtailed macaques (Macaca nemestrina).

Authors:  Derek L Fong; Annie E Torrence; Keith W Vogel; Diane E Stockinger; Veronica Nelson; Robert D Murnane; Audrey Baldessari; LaRene Kuller; Michael Agy; Hans-Peter Kiem; Charlotte E Hotchkiss
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

Review 8.  Nonhuman Primates and Translational Research-Cardiovascular Disease.

Authors:  Laura A Cox; Michael Olivier; Kimberly Spradling-Reeves; Genesio M Karere; Anthony G Comuzzie; John L VandeBerg
Journal:  ILAR J       Date:  2017-12-01

Review 9.  Translational challenges of animal models in Chagas disease drug development: a review.

Authors:  Eric Chatelain; Nandini Konar
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.